Thrilled to share our new @BJUIjournal study! 📊 Quantifying Gleason pattern 4 via MRI & targeted biopsy predicts prostate cancer metastasis better than standard Gleason grading & risk scores. Precision matters in risk stratification. 🔗 doi.org/10.1111/bju.... @vickersbiostats.bsky.social

Happy to share our new meta-analysis that highlights a critical finding: 16% of mCRPC cases treated with ARPIs transition to t-NEPC. Routine biopsies could improve detection of this progression. @chulille.bsky.social @eururoloncol.bsky.social euoncology.europeanurology.com/article/S258...